Concepedia

Philip F. VonVoigtlander

PF

42

Publications

2.6K

Citations

24

H-Index

1974

Active since

Affiliations

W.E. Upjohn Institute for Employment Research(Current)

CNS Research (United States)

University of Notre Dame

Philip F. VonVoigtlander is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1974–1999

42

Publications

42

U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Philip F. VonVoigtlander, Robert A. Lahti, James H. Ludens · Journal of Pharmacology and Experimental Therapeutics · 1983 · 815 citations

Properties of a selective kappa agonist, U-50,488H

Robert A. Lahti, Philip F. VonVoigtlander, Craig L. Barsuhn · Life Sciences · 1982 · 198 citations

, , +3

Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment.

Philip F. VonVoigtlander, Elizabeth G. Losey, Herman J. Triezenberg · Journal of Pharmacology and Experimental Therapeutics · 1975 · 162 citations

Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.

Philip F. VonVoigtlander, R A Lewis · Journal of Pharmacology and Experimental Therapeutics · 1988 · 102 citations

3-Phenyl-Substituted Imidazo[1,5-<i>a</i>]quinoxalin-4-ones and Imidazo[1,5-<i>a</i>]quinoxaline Ureas That Have High Affinity at the GABA<sub>A</sub>/Benzodiazepine Receptor Complex

E. Jon Jacobsen, Lindsay S. Stelzer, Kenneth L. Belonga et al. · Journal of Medicinal Chemistry · 1996 · 91 citations

, , +19

Rows per page

1–5 of 42